tamibarotene has been researched along with Leukemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandraratna, RA; Davies, PJ; Fésüs, L; Heyman, RA; Lamph, W; Nagy, L; Shipley, GL; Thomázy, VA | 1 |
| Bonovolias, ID; Chatzopoulou, M; Demopoulos, VJ; Nicolaou, I; Tsiftsoglou, AS; Vizirianakis, IS | 1 |
| Bian, H; Feng, J; Li, M; Xu, W | 1 |
| Feng, R; Hu, Y; Huang, G; Liu, X; Wang, Z | 1 |
| Duan, Y; Feng, JH; Li, ZT; Pan, XP; Shi, LH; Wang, XJ; Zhang, T; Zhang, XR | 1 |
| Inomata, T; Sunami, K | 1 |
| Chikamatsu, Y; Harigae, H; Ito, S; Kagechika, H; Matsuda, K; Nata, K; Noguchi, N; Okamoto, H; Sugawara, A; Uruno, A; Yoshikawa, T | 1 |
| Malavasi, F | 1 |
| Mitani, K | 1 |
| Ohno, R | 1 |
3 review(s) available for tamibarotene and Leukemia
| Article | Year |
|---|---|
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia; Multipotent Stem Cells; Neoplastic Stem Cells; Pharmacogenetics | 2010 |
[Molecular physiopathology and molecular targeting therapy of leukemia].
Topics: Benzamides; Benzoates; Humans; Imatinib Mesylate; Leukemia; Piperazines; Pyrimidines; Tetrahydronaphthalenes | 2007 |
[Development of anti-leukemic drugs and clinical studies in Japan].
Topics: Antineoplastic Agents; Benzoates; Clinical Trials as Topic; Humans; Informed Consent; International Cooperation; Japan; Leukemia; Tetrahydronaphthalenes; Tretinoin | 1999 |
7 other study(ies) available for tamibarotene and Leukemia
| Article | Year |
|---|---|
Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
Topics: Apoptosis; Benzoates; Binding, Competitive; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Signal Transduction; Structure-Activity Relationship; Tetrahydronaphthalenes; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 1995 |
Novel antileukemic agents derived from tamibarotene and nitric oxide donors.
Topics: Antineoplastic Agents; Benzoates; Cell Proliferation; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia; Molecular Structure; Nitric Oxide Donors; Tetrahydronaphthalenes | 2011 |
A novel approach for systematic delivery of a hydrophobic anti-leukemia agent tamibarotene mediated by nanostructured lipid carrier.
Topics: Animals; Antineoplastic Agents; Benzoates; Delayed-Action Preparations; Diffusion; Hydrophobic and Hydrophilic Interactions; Leukemia; Lipids; Metabolic Clearance Rate; Mice; Nanocapsules; Organ Specificity; Tetrahydronaphthalenes; Tissue Distribution | 2013 |
Preparation and antitumor activity of a tamibarotene-furoxan derivative.
Topics: Animals; Antineoplastic Agents; Benzoates; Blotting, Western; Cell Proliferation; Female; Humans; Leukemia; Mice; Mice, Nude; Models, Chemical; Nitric Oxide; Ovarian Neoplasms; Oxadiazoles; Receptors, Retinoic Acid; Tetrahydronaphthalenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
[Antileukemic].
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzoates; Humans; Leukemia; Oxides; Remission Induction; Tetrahydronaphthalenes; Tretinoin | 2015 |
All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta.
Topics: ADP-ribosyl Cyclase 1; Benzoates; Cell Adhesion; Endothelial Cells; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia; Protein Kinase C-delta; Retinoids; Tetrahydronaphthalenes; Tretinoin | 2011 |
Editorial: CD38 and retinoids: a step toward a cure.
Topics: ADP-ribosyl Cyclase 1; Benzoates; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Tetrahydronaphthalenes; Tretinoin | 2011 |